Gabelli Funds’s Elanco Animal Health ELAN Stock Holding History

Gabelli Funds’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.08M	Sell	125,000 -9,250	-7%	-$214K	0.02%	652
2026 Q1	$3.21M	Buy	134,250 +2,150	+2%	+$52.6K	0.02%	610
2025 Q4	$2.99M	Sell	132,100 -23,900	-15%	-$520K	0.02%	629
2025 Q3	$3.14M	Sell	156,000 -500	-0.3%	-$8.38K	0.02%	624
2025 Q2	$2.23M	Sell	156,500 -3,000	-2%	-$35.1K	0.02%	713
2025 Q1	$1.67M	Sell	159,500 -2,500	-2%	-$28.3K	0.01%	689
2024 Q4	$1.96M	Sell	162,000 -2,500	-2%	-$32.7K	0.01%	656
2024 Q3	$2.42M	Sell	164,500 -3,000	-2%	-$41.8K	0.02%	621
2024 Q2	$2.42M	Hold	167,500	–	–	0.02%	614
2024 Q1	$2.73M	Sell	167,500 -500	-0.3%	-$7.82K	0.02%	590
2023 Q4	$2.5M	Sell	168,000 -10,000	-6%	-$113K	0.02%	616
2023 Q3	$2M	Sell	178,000 -1,500	-0.8%	-$17.4K	0.02%	652
2023 Q2	$1.81M	Buy	179,500 +6,500	+4%	+$60.3K	0.01%	674
2023 Q1	$1.63M	Sell	173,000 -4,000	-2%	-$47.2K	0.01%	704
2022 Q4	$2.16M	Sell	177,000 -47,000	-21%	-$586K	0.02%	639
2022 Q3	$2.78M	Sell	224,000 -5,000	-2%	-$87.4K	0.02%	581
2022 Q2	$4.5M	Buy	229,000 +85,000	+59%	+$2.01M	0.03%	484
2022 Q1	$3.76M	Buy	144,000 +19,000	+15%	+$506K	0.02%	577
2021 Q4	$3.55M	Buy	125,000 +25,950	+26%	+$807K	0.02%	595
2021 Q3	$3.16M	Buy	99,050 +35,050	+55%	+$1.18M	0.02%	626
2021 Q2	$2.22M	Sell	64,000 -500	-0.8%	-$16.5K	0.01%	730
2021 Q1	$1.9M	Buy	64,500 +2,200	+4%	+$67.7K	0.01%	754
2020 Q4	$1.91M	Buy	62,300 +4,800	+8%	+$146K	0.01%	729
2020 Q3	$1.61M	Sell	57,500 -100	-0.2%	-$2.53K	0.01%	731
2020 Q2	$1.24M	Buy	57,600 +700	+1%	+$15.5K	0.01%	762
2020 Q1	$1.27M	Buy	56,900 +11,400	+25%	+$312K	0.01%	738
2019 Q4	$1.34M	Sell	45,500 -500	-1%	-$13.6K	0.01%	804
2019 Q3	$1.22M	Sell	46,000 -650	-1%	-$19.5K	0.01%	821
2019 Q2	$1.58M	Sell	46,650 -9,204	-16%	-$299K	0.01%	810
2019 Q1	$1.79M	Buy	+55,854	New	+$1.72M	0.01%	784

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Gabelli Funds's ELAN Position: Q2 2026 in Review

Gabelli Funds reduced its Elanco Animal Health (ELAN) stake by 6.9% in Q2 2026, selling an estimated $214K and leaving 125,000 shares worth $3.08M. The position accounts for 0.02% of the portfolio, ranked #652.

Gabelli Funds first reported a position in ELAN in Q1 2019 and has held it in 30 quarters since. The position peaked at $4.5M in Q2 2022. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Gabelli Funds held 125,000 shares of Elanco Animal Health worth $3.08M as of Q2 2026.
Gabelli Funds sold 9,250 Elanco Animal Health shares in Q2 2026, an estimated $214K.
Elanco Animal Health made up 0.02% of Gabelli Funds's portfolio in Q2 2026, its #652 holding.
Gabelli Funds first reported a position in Elanco Animal Health in Q1 2019 and has held it in 30 quarters since.
Gabelli Funds's Elanco Animal Health position peaked at $4.5M in Q2 2022.
520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.